Cite
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
MLA
Danser, A. H.Jan, et al. “Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.” Hypertension (Dallas, Tex. : 1979), vol. 75, no. 6, June 2020, pp. 1382–85. EBSCOhost, https://doi.org/10.1161/HYPERTENSIONAHA.120.15082.
APA
Danser, A. H. J., Epstein, M., & Batlle, D. (2020). Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers. Hypertension (Dallas, Tex. : 1979), 75(6), 1382–1385. https://doi.org/10.1161/HYPERTENSIONAHA.120.15082
Chicago
Danser, A H Jan, Murray Epstein, and Daniel Batlle. 2020. “Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.” Hypertension (Dallas, Tex. : 1979) 75 (6): 1382–85. doi:10.1161/HYPERTENSIONAHA.120.15082.